CareLit Fachartikel

CTCtrap – Circulating Tumor Cells TheRapeutic APheresis: a novel biotechnology enabling personalized therapy for all cancer patients

H Neubauer, N Kasprowicz, B Rack, C Vizler, M Scholz, A Ventola, C van Rijn, A Aaspollu, R Zamarchi, G Attard, F Farrace, L Terstappen, T Fehm · Geburtshilfe und Frauenheilkunde · 2014 · Heft 09

Dokument
1174667
CareLit-ID
Jahr
2014
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Geburtshilfe und Frauenheilkunde
Autor:innen
H Neubauer, N Kasprowicz, B Rack, C Vizler, M Scholz, A Ventola, C van Rijn, A Aaspollu, R Zamarchi, G Attard, F Farrace, L Terstappen, T Fehm
Ausgabe
Heft 09 / 2014
Seiten
–
Erschienen: 2014-09-05 00:00:00
ISSN
0016-5751

Zusammenfassung

Circulating tumor cells (CTCs) refer to cells that detach from a primary tumor or metastatic site, circulate in the peripheral blood and may form metastasis. CTC represent a 'liquid biopsy' that can be used to tailor treatment for individual patients. CTC are however rare and can only be obtained for further characterization in a small fraction of patients. In the CTCtrap consortium universities, research institutions and SMEs are linked in a common effort, starting from the simple, but innovative view of using Diagnostic Apheresis (DA), as a way to collect CTC from peripheral blood in cancer patient. A new DA c…

Schlagworte

Apheresis Blood Tumor Biotechnology Diagnosis Biopsy Lead Geburtshilfe und Frauenheilkunde